Evelo Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	1	140	321	477	130	285	60	45
Market Cap Growth	-	-56.30%	-32.71%	267.02%	-54.30%	375.50%	32.62%	-
Enterprise Value	18	144	309	448	72	149	32	40
PE Ratio	-1.38	-1.23	-2.63	-5.10	-1.52	-5.28	-2.13	-3.38
PB Ratio	-2.55	-28.11	37.06	15.66	2.16	2.08	2.04	8.17
P/FCF Ratio	-0.92	-1.38	-3.27	-6.42	-1.73	-5.40	-2.39	-3.33
P/OCF Ratio	-0.92	-1.39	-3.32	-6.53	-1.81	-6.02	-2.57	-3.66
EV/EBITDA Ratio	-1.15	-1.32	-2.69	-4.88	-0.83	-2.56	-1.18	-3.15
EV/EBIT Ratio	-1.13	-1.30	-2.64	-4.78	-0.82	-2.48	-1.15	-3.03
EV/FCF Ratio	-1.15	-1.41	-3.15	-6.03	-0.96	-2.82	-1.26	-2.91
Debt / Equity Ratio	-1.27	-10.24	6.50	1.37	0.33	0.09	0.34	1.80
Debt / EBITDA Ratio	-0.46	-0.47	-0.49	-0.44	-0.23	-0.21	-0.37	-0.79
Debt / FCF Ratio	-0.46	-0.50	-0.57	-0.54	-0.26	-0.23	-0.40	-0.73
Quick Ratio	0.43	3.87	3.94	3.47	7.99	21.95	9.96	6.91
Current Ratio	0.48	4.16	4.09	3.47	7.99	16.02	10.10	6.99
Interest Coverage	9.62	-23.22	-31.95	43.57	-82.32	-37.17	0	0
Return on Equity (ROE)	308.34%	2294.21%	-1409.67%	-307.25%	-142.30%	-39.32%	-95.39%	-241.26%
Return on Assets (ROA)	-399.23%	-177.72%	-139.04%	-103.34%	-94.22%	-33.69%	-64.05%	-71.79%
Return on Capital (ROIC)	-1059.85%	-235.05%	-177.64%	-130.29%	-108.17%	-38.93%	-69.93%	-84.27%
Earnings Yield	-8763.80%	-81.61%	-38.04%	-19.62%	-65.87%	-18.93%	-46.87%	-29.55%
FCF Yield	-7874.00%	-72.58%	-30.59%	-15.58%	-57.68%	-18.54%	-41.79%	-30.06%
Buyback Yield / Dilution	-221.78%	-64.75%	-34.02%	-23.25%	-46.46%	-483.10%	-32.32%	-
Total Shareholder Return	-221.78%	-64.75%	-34.02%	-23.25%	-46.46%	-483.10%	-32.32%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.